KMT2A and acute myeloid leukemia: Moreover, in vivo studies on AML patient-derived xenograft (PDX) model and primary murine MLL-AF9/Flt3ltd/+ model showed convincing anti-leukaemia effect of STM2120 inhibitors [48].